Clover’s journey began as a small family owned company, built by the vision of one man, Hamish Drummond, to improve people’s health with Omega-3 fatty acids. From those humble beginnings, Clover has grown to be an Australian success story.

Publicly listed on the Australian Securities Exchange in 1999, Clover evolved from being a research and development, manufacturing and marketing company to one concentrating on forming strategic relationships focused on technology, new product development and commercialisation.


Today we continue to focus on improving human health through nutrition and have become a global leader in the delivery of stable omega-3 and omega-6 products in to the infant nutrition and medical foods market with a reputation of excellence and quality.

Nu-Mega Lipids JV with Heinz and access to a novel supply of marine omega-3 oil.

A world first introduction of LCPUFA (Long Chain Poly Unsaturated Fatty Acids) via capsules into infant formula.

Began world’s first supply of microencapsulated LCPUFA (Long Chain Poly Unsaturated Fatty Acids) into infant formula.

First in the world to market next generation 50% oil loaded technology.

Developed high temperature stable delivery technology, partnering with a well-known Australian brand, which went on to be one of the most successful functional food launches in the world (adjusted for PPP and population).

Nu-Mega Ingredients formed via JV between Clover Corporation and Food Spectrum.

Nu-Mega Ingredients became 100% subsidiary of Clover Corporation, a consistently profitable, strong, technical, manufacturing and sales organization.

Global leader in delivery of stable micronutrients to the global infant nutrition and special medical market with a reputation for excellence in everything it does.

Beyond 2014, we’re committed to the delivery of the next generation in infant nutrition with a focus on delivering innovative products in the following areas:

Newsletter Subscription

To receive regular updates about Clover, signup below

Privacy Policy